Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes?
Not available.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-06-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12147 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|